Performance of the Xpert® MTB/RIF assay in an active case-finding strategy: A pilot study from Tanzania

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 11, 2012, Pages 1468-1470

  Ntinginya, Nyanda Elias ^a   Squire, S B ^b   Millington, K A ^b   Mtafya, B ^a   Saathoff, E ^c   Heinrich, N ^c   Rojas Ponce, G ^a   Kowuor, D ^a   Maboko, L ^a   Reither, K ^d,e   Clowes, P ^a   Hoelscher, M ^c,f   Rachow, A ^a,c,f  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^e IFAKARA HEALTH INSTITUTE   (Tanzania)

^f German Center for Infection Research   (Germany)

Author keywords

Household contacts; Index cases; Spot spot sputum samples

Indexed keywords

RIFAMPICIN;

ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ASSAY; CASE FINDING; CHILD; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GOLD STANDARD; HUMAN; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MYCOBACTERIUM TUBERCULOSIS; PILOT STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; SPUTUM SMEAR; TANZANIA;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CONTACT TRACING; CROSS-SECTIONAL STUDIES; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; PILOT PROJECTS; SENSITIVITY AND SPECIFICITY; SPUTUM; TANZANIA; TUBERCULOSIS; YOUNG ADULT;

EID: 84867202146     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0127     Document Type: Article

References (10)

1. Ministry of Health and Social Welfare, The United Republic of Tanzania. Manual of the National Tuberculosis and Leprosy Programme in Tanzania. 5th ed. Dar-es-Salaam, Tanzania: Ministry of Health and Social Welfare, 2006.
2. World Health Organization, Stop TB Partnership. Global tuberculosis control. WHO report 2009. Geneva, Switzerland: WHO, 2009: pp 199-216. http://www.stoptb.org/assets/documents/countries/GlobalReport2009/reg/afr.pdf Accessed July 2012.
3. Raviglione M C, Uplekar M W. WHO's new Stop TB Strategy. Lancet 2006; 367: 952-955.
4. Morrison J, Pai M, Hopewell P C. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8: 359-368.
5. Boehme C C, Nicol M P, Nabeta P, et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377: 1495-1505.
6. Jackson-Sillah D, Hill P C, Fox A, et al. Screening for tuberculosis among 2381 household contacts of sputum-smear-positive cases in The Gambia. Trans R Soc Trop Med Hyg 2007; 101: 594-601. (Pubitemid 46586035)
7. Cambanis A, Yassin M A, Ramsay A, Squire S B, Arbide I, Cuevas L E. A one-day method for the diagnosis of pulmonary tuberculosis in rural Ethiopia. Int J Tuberc Lung Dis 2006; 10: 230-232. (Pubitemid 43275551)
8. Cuevas L E, Yassin M A, Al-Sonboli N, et al. A multi-country non-inferiority cluster randomized trial of frontloaded smear microscopy for the diagnosis of pulmonary tuberculosis. PLoS Med 2011; 8: e1000443.
9. Nunn P, Mungai M, Nyamwaya J, et al. The effect of human immunodeficiency virus type-1 on the infectiousness of tuberculosis. Tubercle Lung Dis 1994; 75: 25-32. (Pubitemid 24128756)
10. Rachow A, Zumla A, Heinrich N, et al. Rapid and accurate detection of Mycobacterium tuberculosis in sputum samples by Cepheid Xpert MTB/RIF assay - a clinical validation study. PLoS ONE 2011; 6: e20458.